Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dostert

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Neuroscience Letters|September 9, 2000
Dopaminergic neurotoxins, 6,7-dihydroxy-1-(3', 4'-dihydroxybenzyl)-isoquinolines, cause different types of cell death in SH-SY5Y cells: apoptosis was induced by oxidized papaverolines and necrosis by reduced tetrahydropapaverolinesW Maruyama, K Sango, K Iwasa, et al.
Chirality|January 1, 1995
Stereoselective and species-dependent kinetics of reboxetine in mouse and ratM Strolin Benedetti, E Frigerio, P Tocchetti, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1994
The anticonvulsant FCE 26743 is a selective and short-acting MAO-B inhibitor devoid of inducing properties towards cytochrome P450-dependent testosterone hydroxylation in mice and ratsM S Strolin Benedetti, P Marrari, M Colombo, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 24, 1998
Effects of various tetrahydroisoquinoline derivatives on mitochondrial respiration and the electron transfer complexesN Morikawa, M Naoi, W Maruyama, et al.
Neuroscience Letters|January 12, 1993
Selective release of serotonin by endogenous alkaloids, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, (R)- and (S)salsolinol, in the rat striatum; in vivo microdialysis studyW Maruyama, D Nakahara, P Dostert, et al.
Advances in Neurology|January 1, 1993
Dopamine-derived tetrahydroisoquinolines and Parkinson's diseaseP Dostert, M Strolin Benedetti, F Della Vedova, et al.
Pharmacological Research|January 7, 2000
Species-differences in disposition and reductive metabolism of methoxymorpholinodoxorubicin (PNU 152243), a new potential anticancer agentM Breda, M S Benedetti, R Battaglia, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Lack of pharmacokinetic interaction between the selective dopamine agonist cabergoline and the MAO-B inhibitor selegilineP Dostert, M Strolin Benedetti, S Persiani, et al.
Journal of Chromatography|July 1, 1992
Endogenous synthesis of N-methylsalsolinol, an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in rat brain during in vivo microdialysis with salsolinol, as demonstrated by gas chromatography-mass spectrometryT Niwa, W Maruyama, D Nakahara, et al.
British Journal of Clinical Pharmacology|December 1, 1996
Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humansY Böttiger, P Dostert, M S Benedetti, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Neuroscience Letters|September 9, 2000
Dopaminergic neurotoxins, 6,7-dihydroxy-1-(3', 4'-dihydroxybenzyl)-isoquinolines, cause different types of cell death in SH-SY5Y cells: apoptosis was induced by oxidized papaverolines and necrosis by reduced tetrahydropapaverolinesW Maruyama, K Sango, K Iwasa, et al.
Chirality|January 1, 1995
Stereoselective and species-dependent kinetics of reboxetine in mouse and ratM Strolin Benedetti, E Frigerio, P Tocchetti, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1994
The anticonvulsant FCE 26743 is a selective and short-acting MAO-B inhibitor devoid of inducing properties towards cytochrome P450-dependent testosterone hydroxylation in mice and ratsM S Strolin Benedetti, P Marrari, M Colombo, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 24, 1998
Effects of various tetrahydroisoquinoline derivatives on mitochondrial respiration and the electron transfer complexesN Morikawa, M Naoi, W Maruyama, et al.
Neuroscience Letters|January 12, 1993
Selective release of serotonin by endogenous alkaloids, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, (R)- and (S)salsolinol, in the rat striatum; in vivo microdialysis studyW Maruyama, D Nakahara, P Dostert, et al.
Advances in Neurology|January 1, 1993
Dopamine-derived tetrahydroisoquinolines and Parkinson's diseaseP Dostert, M Strolin Benedetti, F Della Vedova, et al.
Pharmacological Research|January 7, 2000
Species-differences in disposition and reductive metabolism of methoxymorpholinodoxorubicin (PNU 152243), a new potential anticancer agentM Breda, M S Benedetti, R Battaglia, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Lack of pharmacokinetic interaction between the selective dopamine agonist cabergoline and the MAO-B inhibitor selegilineP Dostert, M Strolin Benedetti, S Persiani, et al.
Journal of Chromatography|July 1, 1992
Endogenous synthesis of N-methylsalsolinol, an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in rat brain during in vivo microdialysis with salsolinol, as demonstrated by gas chromatography-mass spectrometryT Niwa, W Maruyama, D Nakahara, et al.
British Journal of Clinical Pharmacology|December 1, 1996
Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humansY Böttiger, P Dostert, M S Benedetti, et al.
Pageof 11